More recent 3- and 4-year Phase 3 CheckMate metastatic non-small cell lung cance... | Hacker News

Hacker Newsnew | past | comments | ask | show | jobs | submit

		starkparker on Aug 2, 2023 \| parent \| context \| favorite \| on: Cancer pill AOH1996 shows promise in annihilating ... More recent 3- and 4-year Phase 3 CheckMate metastatic non-small cell lung cancer trial results were also good, if less dramatic. ESMO summary: https://dailyreporter.esmo.org/european-lung-cancer-congress... 4-year trial PR: https://news.bms.com/news/details/2023/Four-Year-Outcomes-fr... 3-year trial abstract: https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.8521

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact